123 related articles for article (PubMed ID: 14604779)
21. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
[TBL] [Abstract][Full Text] [Related]
22. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.
Fujimura M; Hashimoto K; Yamagami K
Eur J Pharmacol; 2000 Jun; 398(1):1-10. PubMed ID: 10856442
[TBL] [Abstract][Full Text] [Related]
23. The role of NMDA receptors in regulating group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex.
Huang CC; Hsu KS
Neuropharmacology; 2008 Jun; 54(7):1071-8. PubMed ID: 18378263
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys.
Adewale AS; Platt DM; Spealman RD
J Pharmacol Exp Ther; 2006 Aug; 318(2):922-31. PubMed ID: 16675638
[TBL] [Abstract][Full Text] [Related]
25. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
Fell MJ; Katner JS; Johnson BG; Khilevich A; Schkeryantz JM; Perry KW; Svensson KA
Neuropharmacology; 2010 Mar; 58(3):632-9. PubMed ID: 19951716
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury.
Movsesyan VA; Faden AI
J Neurotrauma; 2006 Feb; 23(2):117-27. PubMed ID: 16503796
[TBL] [Abstract][Full Text] [Related]
27. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
[TBL] [Abstract][Full Text] [Related]
28. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
29. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268.
Cartmell J; Monn JA; Schoepp DD
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):39-46. PubMed ID: 10651145
[TBL] [Abstract][Full Text] [Related]
30. Dizocilpine-induced neuropathological changes in rat retrosplenial cortex are reversed by subsequent clozapine treatment.
Hashimoto K; Fujimura M; Yamagami K
Life Sci; 2000 Feb; 66(12):1071-8. PubMed ID: 10737357
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
[TBL] [Abstract][Full Text] [Related]
32. Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801.
Okamura N; Reinscheid RK; Ohgake S; Iyo M; Hashimoto K
Neuropharmacology; 2010 Jan; 58(1):166-72. PubMed ID: 19576911
[TBL] [Abstract][Full Text] [Related]
33. Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice.
Takatsu Y; Fujita Y; Tsukamoto T; Slusher BS; Hashimoto K
Brain Res; 2011 Jan; 1371():82-6. PubMed ID: 21093418
[TBL] [Abstract][Full Text] [Related]
34. LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.
Bond A; Ragumoorthy N; Monn JA; Hicks CA; Ward MA; Lodge D; O'Neill MJ
Neurosci Lett; 1999 Oct; 273(3):191-4. PubMed ID: 10515191
[TBL] [Abstract][Full Text] [Related]
35. Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
Neuropharmacology; 2001 Jun; 40(7):847-55. PubMed ID: 11378155
[TBL] [Abstract][Full Text] [Related]
36. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
38. Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Battaglia G; Busceti CL; Pontarelli F; Biagioni F; Fornai F; Paparelli A; Bruno V; Ruggieri S; Nicoletti F
Neuropharmacology; 2003 Aug; 45(2):155-66. PubMed ID: 12842121
[TBL] [Abstract][Full Text] [Related]
39. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
[TBL] [Abstract][Full Text] [Related]
40. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.
Fix AS; Horn JW; Wightman KA; Johnson CA; Long GG; Storts RW; Farber N; Wozniak DF; Olney JW
Exp Neurol; 1993 Oct; 123(2):204-15. PubMed ID: 8405286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
